Status:
COMPLETED
Incidence, Clinical Characteristics and Prognosis of Patients With ST-segment Elevation Myocardial Infarction (STEMI) and Spontaneous Coronary Reperfusion in the Modern Antithrombotic Strategy Area
Lead Sponsor:
University Hospital, Montpellier
Collaborating Sponsors:
Centre Hospitalier Universitaire de Nīmes
Conditions:
Coronary Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
The rapid and complete restoration of coronary flow is a key issue in the management of STEMI. Primary percutaneous coronary intervention (PCI) is the preferred reperfusion strategy associated with an...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Older than 18 years old.
- patients with ongoing (within 12 hours after onset of symptoms) STEMI admitted for coronary angiography and receiving preloading dose of aspirin, heparin and P2Y12 inhibitor
- Exclusion criteria:
- Patients with thrombolysis treatment before angiography
- Patients with cardiac arrest without ST-segment elevation on ECG after resuscitation
- Patients with myocardial infarction outside of acute phase (pain lasting more 12 hours)
- Patients with mental disease
- Patients not living in France
Exclusion
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2021
Estimated Enrollment :
302 Patients enrolled
Trial Details
Trial ID
NCT04881552
Start Date
June 1 2020
End Date
May 1 2021
Last Update
May 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295